Gallian P., Lamballerie X. de, De Micco P., Andreu G. (2005). West Nile Virus (WNV): implication and generalities in blood transfusion. Transfusion Clinique Et Biologique, 12 (1), p. 11-17. ISSN 1246-7820.
Titre du document
West Nile Virus (WNV): implication and generalities in blood transfusion
Gallian P., Lamballerie X. de, De Micco P., Andreu G.
Source
Transfusion Clinique Et Biologique, 2005,
12 (1), p. 11-17 ISSN 1246-7820
West Nile virus (WNV) is an arbovirus (genus Flavivirus, Family Flaviviridae, transmitted to humans by mosquito bite. In most cases (80%), human infection remains asymptomatic. Severe central nervous system complications (encephalitis and meningoencephalitis) are rare. In the Old World, the virus circulation has been demonstrated in Asia, Australia, Africa, Middle East and Europe. Several outbreaks in humans have been described. Following its introduction into North America in 1999, WN virus has been responsible of a large number of human cases in USA and Canada. For the first time, viral transmission by blood products was clearly demonstrated in USA in 2002. In France, the presence of virus has been reported in the Southeasthern departments since 1962. In 2003, the occurrence of humans cases at specific geographical foci urged the French National Blood Agency (etablissement francais du sang) to take preventive measures for evaluating the virus transmission risks. (c) 2005 Elsevier SAS. Tous droits reserves.
